The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.
Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications
Open accessAbstract
Copper is one of the most abundant basic transition metals in the human body. It takes part in oxygen metabolism, collagen synthesis, and skin pigmentation, maintaining the integrity of blood vessels, as well as in iron homeostasis, antioxidant defense, and neurotransmitter synthesis. It may also be involved in cell signaling and may participate in modulation of membrane receptor-ligand interactions, control of kinase and related phosphatase functions, as well as many cellular pathways. Its role is also important in controlling gene expression in the nucleus. In the nervous system in particular, copper is involved in myelination, and by modulating synaptic activity as well as excitotoxic cell death and signaling cascades induced by neurotrophic factors, copper is important for various neuronal functions. Current data suggest that both excess copper levels and copper deficiency can be harmful, and careful homeostatic control is important. This knowledge opens up an important new area for potential therapeutic interventions based on copper supplementation or removal in neurodegenerative diseases including Wilson’s disease (WD), Menkes disease (MD), Alzheimer’s disease (AD), Parkinson’s disease (PD), and others. However, much remains to be discovered, in particular, how to regulate copper homeostasis to prevent neurodegeneration, when to chelate copper, and when to supplement it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–250 of 250
Biochemical markers for the diagnosis and monitoring of Wilson Disease
Mohr, I., & Weiss, K. H. (2019) · Clinical Biochemist Reviews · doi:10.33176/aacb-18-00014 · Cited by 66
Bauerly, K. A., Kelleher, S. L., & Lönnerdal, B. L. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00210.2004 · Cited by 62
Kessler, H., Pajonk, F.-G., Bach, D., Schneider-Axmann, T., Falkai, P., Herrmann, W., Multhaup, G., Wiltfang, J., Schäfer, S., Wirths, O., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0136-2 · Cited by 61
Delivery of Curcumin and Medicinal Effects of the Copper(II)-Curcumin Complexes
Leung, M. H. M., Harada, T., & Kee, T. W. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289237 · Cited by 60
Linnebank, M., Lutz, H. H., Jarre, E., Vielhaber, S., Noelker, C., Struys, E. A., Jakobs, C., Klockgether, T., Evert, B. O., Kunz, W. S., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.010 · Cited by 59
Li, P., & Zhang, Y. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_9 · Cited by 58
Venti, A., Giordano, T., Eder, P. S., Bush, A. I., Lahiri, D. K., Greig, N. H., & Rogers, J. T. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.003 · Cited by 58
The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease
Sosunov, A. A., McKhann, G. M., & Goldman, J. E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0425-9 · Cited by 57
Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis
Gil-Bea, F. J., Aldanondo, G., Lasa-Fernández, H., de Munaín, A. L., & Vallejo‐Illarramendi, A. (2017) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2017.9 · Cited by 57
Gromadzka, G., Rudnicka, M., Chabik, G., Przybyłkowski, A. M., & Członkowska, A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.030 · Cited by 56
Self-citationTranscriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1
Vargas, M. R., Pehar, M., Díaz‐Amarilla, P., Beckman, J. S., & Barbeito, L. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21797 · Cited by 56
Allen, K. J., Buck, N. E., Cheah, D. M. Y., Gazeas, S., Bhathal, P. S., & Mercer, J. F. B. (2006) · BioMetals · doi:10.1007/s10534-005-5918-5 · Cited by 56
Disturbed Copper Bioavailability in Alzheimer′s Disease
Kaden, D., Bush, A. I., Danzeisen, R., Bayer, T. A., & Multhaup, G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/345614 · Cited by 55
Increased cerebral iron uptake in Wilson's disease: a 52Fe-citrate PET study.
Bruehlmeier, M., Leenders, K. L., Vontobel, P., Calonder, C., Antonini, A., & Weindl, A. (2000) · PubMed · Cited by 55
Clioquinol for the treatment of Alzheimer's Disease
Jenagaratnam, L., & McShane, R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005380.pub2 · Cited by 54
Nishiyama, K., Murayama, S., Shimizu, J., Ohya, Y., Kwak, S., Asayama, K., & Kanazawa, I. (1995) · Acta Neuropathologica · doi:10.1007/bf00571500 · Cited by 54
Skopp, A., Boyd, S. D., Ullrich, M. S., Liu, L., & Winkler, D. D. (2019) · BioMetals · doi:10.1007/s10534-019-00206-3 · Cited by 54
NGF promotes copper accumulation required for optimum neurite outgrowth and protein methylation
Birkaya, B. G., & Aletta, J. M. (2004) · Journal of Neurobiology · doi:10.1002/neu.20114 · Cited by 51
Copper, BDNF and Its N‐terminal Domain: Inorganic Features and Biological Perspectives
Travaglia, A., Mendola, D. L., Magrì, A. L., Nicoletti, V. G., Pietropaolo, A., & Rizzarelli, E. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202775 · Cited by 50
Apolipoprotein E gene (APOE) genotype in Wilson’s disease: Impact on clinical presentation
Litwin, T., Gromadzka, G., & Członkowska, A. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.12.005 · Cited by 49
Self-citationAlpha-synuclein: relating metals to structure, function and inhibition
McDowall, J., & Brown, D. R. (2016) · Metallomics · doi:10.1039/c6mt00026f · Cited by 47
Prevention of mutant SOD1 motoneuron degeneration by copper chelatorsin vitro
Azzouz, M., Poindron, P., Guettier‐Sigrist, S., Leclerc, N., Andres, C. R., Warter, J., & Borg, J. (2000) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(200001)42:1<49::aid-neu5>3.0.co;2-7 · Cited by 44
Neurotoxic effects of homocysteine on cerebellar Purkinje neurons in vitro
Oldreive, C., & Doherty, G. H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.11.031 · Cited by 42
The Blood-Cerebrospinal Fluid Barrier
(2005) · CRC Press eBooks · doi:10.1201/9780367801007 · Cited by 40
Transcranial sonography in Wilson’s disease
Svetel, M. V., Mijajlovic, M. D., Tomić, A., Kresojević, N. D., Pekmezovic, T. D., & Kostić, V. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.10.007 · Cited by 40
Николаевна, Н. И., Satriano, C., Pietropaolo, A., Gianì, F., Pandini, G., Triaca, V., Amadoro, G., Latina, V., Calissano, P., Travaglia, A., et al. (2019) · Cells · doi:10.3390/cells8040301 · Cited by 40
Copper as the most likely pathogenic divergence factor between lung fibrosis and emphysema
Janssen, R., de Brouwer, B., von der Thüsen, J. H., & Wouters, E. F. �. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.08.003 · Cited by 39
Wang, W., Post, J. I., Dow, K. E., Shin, S. H., Riopelle, R. J., & Ross, G. M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00929-x · Cited by 38
Tassabehji, N. M., VanLandingham, J. W., & Levenson, C. W. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523001002 · Cited by 37
Roberti, M. D. R. F., Filho, H. M. B., Gonçalves, C. H., & Lima, F. L. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110104 · Cited by 35
Effective inhibition of copper-catalyzed production of hydroxyl radicals by deferiprone
Timoshnikov, V. A., Kobzeva, T. V., Selyutina, O. Y., Polyakov, N. E., & Kontoghiorghes, G. J. (2019) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-019-01650-9 · Cited by 35
Copper Deficiency Exacerbates Bile Duct Ligation-Induced Liver Injury and Fibrosis in Rats
Song, M., Zhou, Z., Chen, T., Zhang, J., & McClain, C. J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184325 · Cited by 34
Copper relay path through the N-terminus of Wilson disease protein, ATP7B
Shanmugavel, K. P., & Wittung-Stafshede, P. E. (2019) · Metallomics · doi:10.1039/c9mt00147f · Cited by 34
WTX101 – an investigational drug for the treatment of Wilson disease
Weiss, K. H., Członkowska, A., Hedera, P., et al. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1482274 · Cited by 31
Metal protein attenuating compounds for the treatment of Alzheimer's disease
Sampson, E. L., Jenagaratnam, L., & McShane, R. H. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005380.pub3 · Cited by 31
Copper export from cultured astrocytes
Scheiber, I. F., Schmidt, M., & Dringen, R. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.12.012 · Cited by 30
Walter, U., Skowrońska, M., Litwin, T., Szpak, G. M., Jabłonka-Salach, K., Školoudík, D., Bulska, E., & Członkowska, A. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1184-4 · Cited by 29
Maher, P. A., & Kontoghiorghes, G. J. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1508-7 · Cited by 28
Iron and glutathione at the crossroad of redox metabolism in neurons
Aracena-Parks, P., Aguirre, P., Muñoz, P., & Núñez, M. T. (2006) · Biological Research · doi:10.4067/s0716-97602006000100017 · Cited by 28
Ross, G. M., Shamovsky, I. L., Woo, S. B., Post, J. I., Vrkljan, P. N., Lawrance, G. M., Solc, M., Dostaler, S. M., Neet, K., & Riopelle, R. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00427.x · Cited by 25
Gromadzka, G., Kruszyńska, M., Wierzbicka, D., Litwin, T., Dzieżyc, K., Wierzchowska‐Ciok, A., Chabik, G., & Członkowska, A. (2014) · Liver International · doi:10.1111/liv.12493 · Cited by 23
Self-citationGromadzka, G., & Członkowska, A. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.523131 · Cited by 23
Self-citationIn Vitro Interaction Between Homocysteine and Copper Ions: Potential Redox Implications
Carrasco‐Pozo, C., Álvarez‐Lueje, A., Olea‐Azar, C., López‐Alarcón, C., & Speisky, H. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100918 · Cited by 22
Copper amine oxidases catalyze the oxidative deamination and hydrolysis of cyclic imines
Nagakubo, T., Kumano, T., Ohta, T., Hashimoto, Y., & Kobayashi, M. (2019) · Nature Communications · doi:10.1038/s41467-018-08280-w · Cited by 22
Tarnacka, B., Szeszkowski, W., Gołębiowski, M., & Członkowska, A. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.007 · Cited by 21
Self-citationGromadzka, G., Karpińska, A., Przybyłkowski, A. M., Litwin, T., Wierzchowska‐Ciok, A., Dzieżyc, K., Chabik, G., & Członkowska, A. (2013) · BioMetals · doi:10.1007/s10534-013-9694-3 · Cited by 21
Self-citationRío, R. D., Quintanilla, R. A., Orellana, J. A., & Retamal, M. A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00350 · Cited by 21
Molecular Factors Affecting the Complex Formation between Deferiprone (L1) and Cu(II)
Pashalidis, I., & Kontoghiorghes, G. J. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300151 · Cited by 15
Roudeau, S., Chevreux, S., Carmona, A., & Ortega, R. (2015) · Electrophoresis · doi:10.1002/elps.201500187 · Cited by 14
Regulation of Neuroactive Metals by the Choroid Plexus
Li, G. J., & Zheng, W. (2005) · CRC Press eBooks · doi:10.1201/9781420023404.ch9 · Cited by 9
Cited by
Zirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V., & Plemel, J. R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00538-8 · Cited by 270
Exposure of metal toxicity in Alzheimer’s disease: An extensive review
Islam, F., Shohag, S., Akhter, S., Islam, M. R., Sultana, S., Mitra, S., Chandran, D., Khandaker, M. U., Ashraf, G. M., Idris, A. M., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.903099 · Cited by 83
Metadata
- Authors
- Gromadzka, G., Tarnacka, B., Flaga, A., & Adamczyk, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-12-04
- Volume
- 21
- Issue
- 23
- Pages
- 9259
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3108197638
- Cited by
- 339
- References
- 250
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.